WallStreetZenWallStreetZen

NASDAQ: HZNP
Horizon Therapeutics Public Ltd Co Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for HZNP

Based on 7 analysts offering 12 month price targets for Horizon Therapeutics Public Ltd Co.
Min Forecast
$71.00+14.72%
Avg Forecast
$111.29+79.81%
Max Forecast
$144.00+132.67%

Should I buy or sell HZNP stock?

Based on 7 analysts offering ratings for Horizon Therapeutics Public Ltd Co.
Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HZNP stock forecasts and price targets.

HZNP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BMO Capital
Bottom 18%
18
BuyMaintains$117.00+89.05%2022-08-04
Morgan Stanley
Bottom 13%
13
Strong BuyMaintains$90.00+45.42%2022-08-04
Goldman Sachs
Top 2%
99
Strong BuyMaintains$144.00+132.67%2022-08-04
UBS
Bottom 22%
22
HoldDowngrades$71.00+14.72%2022-08-04
SVB Leerink
Top 13%
88
BuyUpgrades$80.00+29.26%2022-08-04
Anonymous
Morgan Stanley
Strong BuyMaintains$135.00+118.13%2022-05-05
Oppenheimer
Bottom 8%
8
BuyInitiates Coverage On$140.00+126.21%2022-03-15
Wells Fargo
Top 13%
88
Strong BuyInitiates Coverage On$137.00+121.36%2021-12-08

1 of 1

Forecast return on equity

Is HZNP forecast to generate an efficient return?
Company
35.87%
Industry
91.67%
Market
121.74%
HZNP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HZNP forecast to generate an efficient return on assets?
Company
20.04%
Industry
17.84%
HZNP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HZNP earnings per share forecast

What is HZNP's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$4.27+27.08%
Avg 2 year Forecast
$5.41+61.01%
Avg 3 year Forecast
$6.74+100.6%
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HZNP revenue forecast

What is HZNP's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$3.6B-5.08%
Avg 2 year Forecast
$4.1B+6.66%
Avg 3 year Forecast
$4.6B+21.61%
HZNP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HZNP earnings growth forecast

How is HZNP forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
25.88%
Industry
13.64%
Market
16.88%
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HZNP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HZNP revenue growth forecast

How is HZNP forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
6.74%
Industry
0.94%
Market
8.59%
HZNP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HZNP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HZNP vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
HZNP$61.89$111.29+79.81%Strong Buy
OGN$23.40$36.25+54.91%Buy
GRFS$6.16N/AN/AHold
TSVT$14.55$32.75+125.09%Strong Buy
BIIB$267.00$278.33+4.24%Buy

Horizon Therapeutics Public Co Stock Forecast FAQ

Is Horizon Therapeutics Public Co Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: HZNP) stock is to Strong Buy HZNP stock.

Out of 7 analysts, 3 (42.86%) are recommending HZNP as a Strong Buy, 3 (42.86%) are recommending HZNP as a Buy, 1 (14.29%) are recommending HZNP as a Hold, 0 (0%) are recommending HZNP as a Sell, and 0 (0%) are recommending HZNP as a Strong Sell.

If you're new to stock investing, here's how to buy Horizon Therapeutics Public Co stock.

What is HZNP's earnings growth forecast for 2022-2024?

(NASDAQ: HZNP) Horizon Therapeutics Public Co's forecast annual earnings growth rate of 25.88% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 13.64%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Horizon Therapeutics Public Co's earnings in 2022 is $764,960,000.On average, 8 Wall Street analysts forecast HZNP's earnings for 2022 to be $983,741,273, with the lowest HZNP earnings forecast at $912,322,117, and the highest HZNP earnings forecast at $1,075,895,022. On average, 9 Wall Street analysts forecast HZNP's earnings for 2023 to be $1,246,379,458, with the lowest HZNP earnings forecast at $1,145,010,334, and the highest HZNP earnings forecast at $1,380,002,394.

In 2024, HZNP is forecast to generate $1,552,790,674 in earnings, with the lowest earnings forecast at $1,308,583,239 and the highest earnings forecast at $1,734,794,329.

What is HZNP's revenue growth forecast for 2022-2024?

(NASDAQ: HZNP) Horizon Therapeutics Public Co's forecast annual revenue growth rate of 6.74% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 0.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.59%.

Horizon Therapeutics Public Co's revenue in 2022 is $3,813,112,000.On average, 7 Wall Street analysts forecast HZNP's revenue for 2022 to be $833,882,228,067, with the lowest HZNP revenue forecast at $810,722,608,587, and the highest HZNP revenue forecast at $907,906,570,187. On average, 7 Wall Street analysts forecast HZNP's revenue for 2023 to be $936,999,048,041, with the lowest HZNP revenue forecast at $848,044,877,013, and the highest HZNP revenue forecast at $1,104,601,836,323.

In 2024, HZNP is forecast to generate $1,068,313,302,579 in revenue, with the lowest revenue forecast at $909,787,888,977 and the highest revenue forecast at $1,282,791,247,314.

What is HZNP's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: HZNP) forecast ROA is 20.04%, which is higher than the forecast US Drug Manufacturers - General industry average of 17.84%.

What is HZNP's Price Target?

According to 7 Wall Street analysts that have issued a 1 year HZNP price target, the average HZNP price target is $111.29, with the highest HZNP stock price forecast at $144.00 and the lowest HZNP stock price forecast at $71.00.

On average, Wall Street analysts predict that Horizon Therapeutics Public Co's share price could reach $111.29 by Aug 4, 2023. The average Horizon Therapeutics Public Co stock price prediction forecasts a potential upside of 79.81% from the current HZNP share price of $61.89.

What is HZNP's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: HZNP) Horizon Therapeutics Public Co's current Earnings Per Share (EPS) is $3.36. On average, analysts forecast that HZNP's EPS will be $4.27 for 2022, with the lowest EPS forecast at $3.96, and the highest EPS forecast at $4.67. On average, analysts forecast that HZNP's EPS will be $5.41 for 2023, with the lowest EPS forecast at $4.97, and the highest EPS forecast at $5.99. In 2024, HZNP's EPS is forecast to hit $6.74 (min: $5.68, max: $7.53).

What is HZNP's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: HZNP) forecast ROE is 35.87%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.